Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 5/20 | 0.41 |
| ▸ | UCHL1 | P09936 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GHSR | Q92847 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL564701 | 0.85 | NPC1 (0.52) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL564702 | 0.85 | NPC1 (0.52) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL883239 | 0.83 | NPC1 (0.59) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL697981 | 0.81 | ALDH1A1 (0.47) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL883027 | 0.79 | HTR2C (0.46) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL11910976 | 0.77 | NPC1 (0.60) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL14845515 | 0.77 | NPC1 (0.60) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL19789881 | 0.76 | LMNA (0.60) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL571211 | 0.75 | NPC1 (0.58) | ALDH1A1NPC1USP30UCHL1LMNA | |
| SCHEMBL883143 | 0.75 | NPC1 (0.58) | ALDH1A1NPC1USP30UCHL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436036-B2 | Diaryl ethers | JANSSEN R&D IRELAND (IE) | 2013-05-07 | — | — | US | disclosed |
| US-20120034678-A1 | Diaryl Ethers | JANSSEN SCIENCES IRELAND UC (IE) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034678-A1 | Diaryl Ethers | SLC10A1, CYP2F1, UGT1A1 | ALDH1A1 325/4885NPC1 62/4885USP30 2753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.